Dr. Reddy’s Laboratories informs about update on inspection

12 Aug 2024 Evaluate

Further to its intimation dated May 17, 2024, on the inspection conducted by the United States Food & Drug Administration (USFDA) at its formulations manufacturing facilities (FTO-7 & FTO-9) in Duvvada, Visakhapatnam, Dr. Reddy’s Laboratories has informed that the Company has received the Establishment Inspection Report (EIR). The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is ‘closed’ under 21 CFR 20.64(d)(3).

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1194.55 -19.40 (-1.60%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.